Anavex Life Sciences
AVXL
AVXL
146 hedge funds and large institutions have $251M invested in Anavex Life Sciences in 2022 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 51 increasing their positions, 31 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
16% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 19
33% less call options, than puts
Call options by funds: $15.2M | Put options by funds: $22.7M
Holders
146
Holding in Top 10
–
Calls
$15.2M
Puts
$22.7M
Top Buyers
| 1 | +$1.85M | |
| 2 | +$1.43M | |
| 3 | +$1.24M | |
| 4 |
Rafferty Asset Management
New York
|
+$1.11M |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$949K |
Top Sellers
| 1 | -$6.47M | |
| 2 | -$4.24M | |
| 3 | -$2.39M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$1.32M |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
-$1.3M |